Garg Pushkal
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Garg Pushkal. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ALNY | EVP Chief R&D | Sale | 215 | $454.37 | $97,690 | Oct 2, 2025 |
| ALNY | EVP Chief R&D | Sale | 276 | $455.41 | $125,693 | Aug 18, 2025 |
| ALNY | CMO & EVP Dev & Med Affairs | Sale | 4,321 | $285.00 | $1,231,485 | Mar 24, 2025 |
| ALNY | CMO & EVP Dev & Med Affairs | Sale | 116 | $245.26 | $28,450 | Mar 3, 2025 |
| ALNY | CMO & EVP Dev & Med Affairs | Sale | 91 | $240.32 | $21,869 | Feb 28, 2025 |
| ALNY | CMO & EVP Dev & Med Affairs | Sale | 306 | $250.73 | $76,723 | Feb 18, 2025 |
| ALNY | CMO & EVP Dev & Med Affairs | Option Exercise | 23,876 | $88.95 | $2,123,770 | Jan 27, 2025 |
| ALNY | CMO & EVP Dev & Med Affairs | Sale | 100 | $252.94 | $25,294 | Dec 12, 2024 |
| ALNY | CMO & EVP Dev & Med Affairs | Sale | 97 | $252.27 | $24,470 | Nov 25, 2024 |
| ALNY | CMO & EVP Dev & Med Affairs | Award / Grant | 96 | — | — | Oct 8, 2024 |
| ALNY | CMO & EVP Dev & Med Affairs | Sale | 45 | $226.82 | $10,207 | Jun 25, 2024 |
| ALNY | CMO & EVP Dev & Med Affairs | Award / Grant | 4,751 | — | — | Mar 1, 2024 |
| ALNY | CMO & EVP Dev & Med Affairs | Sale | 1 | $158.09 | $158 | Feb 28, 2024 |
| ALNY | CMO & EVP Dev & Med Affairs | Sale | 480 | $147.50 | $70,800 | Feb 15, 2024 |
| ALNY | CMO & EVP Dev & Med Affairs | Award / Grant | 4,518 | — | — | Aug 4, 2023 |
| ALNY | CMO & EVP Dev & Med Affairs | Sale | 779 | $194.94 | $151,858 | Apr 27, 2023 |
| ALNY | CMO & EVP Dev & Med Affairs | Option Exercise | 2,500 | $96.45 | $241,125 | Mar 3, 2023 |
| ALNY | CMO & EVP Dev & Med Affairs | Tax Withholding | 4,603 | $189.76 | $873,465 | Aug 4, 2022 |